Zim Laboratories Ltd

Fri 10/07/2026,14:46:33 | NSE : ZIMLAB

₹113.62-2.31 (-1.99%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 113.62

Previous Close

₹ 115.93

Volume

13401

Mkt Cap ( Rs. Cr)

₹608.42

High

₹ 113.92

Low

₹ 113.62

52 Week High

₹ 133.90

52 Week Low

₹ 59.31

Book Value Per Share

₹ 55.31

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Zim Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Zim Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Zim Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2026, 6:49PM Certificate under Reg 74(5) of SEBI (DP) Regulations,2018 for the quarter ended 30th June 2026 is enclosed herewith.

  • Zim Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    10 Jul 2026, 6:46PM Zim Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    10 Jul 2026, 5:48PM Please find enclosed the Postal Ballot Notice of the Company, for your reference.

  • Zim Laboratories - Shareholders meeting

    10 Jul 2026, 5:46PM Zim Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jun 2026, 10:36PM Disclosure under Regulation 30 of SEBI (LODR) 2015, with respect to schedule of Investor/ Analyst Meeting

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Jun 2026, 10:35PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Jun 2026, 3:30PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jun 2026, 3:35PM Disclosure under Regulation 30 of SEBI (LODR) 2015, with respect to schedule of Investor/ Analyst Meeting

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Jun 2026, 7:40PM Please find enclosed the Proceedings of the 42nd Annual General Meeting held on 29th June 2026 along with the Scrutinizers Report.

  • Zim Laboratories - Shareholders meeting

    29 Jun 2026, 7:35PM Zim Laboratories Limited has informed the Exchange regarding voting results of Annual General Meeting held on Jun 29, 2026

  • Zim Laboratories - Shareholders meeting

    29 Jun 2026, 7:33PM Zim Laboratories Limited has informed the Exchange about Shareholders meeting

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    29 Jun 2026, 7:46PM Please find enclosed the Voting Results under Regulation 44 of SEBI (LODR) Regulations 2015 along with the Scrutinizers Report of the 42nd Annual Gene

  • Zim Laboratories - Trading Window

    25 Jun 2026, 12:10PM Zim Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Zim Laboratories - Disclosure under SEBI Takeover Regulations

    16 Jun 2026, 5:50PM ANWAR SIRAJ DAUDÿhas submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition mad

  • Zim Laboratories - Copy of Newspaper Publication

    6 Jun 2026, 1:09PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - General Updates

    5 Jun 2026, 7:05PM Zim Laboratories Limited has informed the Exchange about letter send to members providing web link of Annual Report FY 25-26

  • Zim Laboratories - Letter Sent To Members

    5 Jun 2026, 7:03PM Pursuant to Regulation 36(1)(b) of SEBI(LODR) Regulations 2015 please find enclosed the letter sent to members providing weblink of Annual Report for

  • Zim Laboratories - Reg. 34 (1) Annual Report.

    5 Jun 2026, 6:04PM Please find enclosed the Annual Report for the F.Y. 2025-26.

  • Zim Laboratories - The Notice Of 42Nd Annual General Meeting For The F.Y 2025-26

    5 Jun 2026, 5:52PM The Notice of 42nd Annual General Meeting along with the Annual Report for the F.Y 2025-26 is enclosed.

  • Zim Laboratories - Shareholders meeting

    5 Jun 2026, 5:51PM Zim Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 29, 2026

  • Zim Laboratories - Disclosure under SEBI Takeover Regulations

    4 Jun 2026, 7:26PM ÿAnwar Daudÿhas Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acqu

  • Zim Laboratories - Copy of Newspaper Publication

    30 May 2026, 1:45PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication-Corrigendum

  • Zim Laboratories - Copy of Newspaper Publication

    26 May 2026, 4:12PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    23 May 2026, 4:01PM Transcript of Q4 & FY26 Earnings Conference Call

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    23 May 2026, 3:55PM Zim Laboratories Limited has informed the Exchange about Transcript

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    20 May 2026, 8:17PM Enclosed the disclosure with the link for the audio recording of the Q4 & FY26 Earnings Conference Call

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    20 May 2026, 8:08PM Zim Laboratories Limited has informed the Exchange about Link of Recording

  • Zim Laboratories - Copy of Newspaper Publication

    20 May 2026, 1:01PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - Earnings Presentation Q4 & FY26

    19 May 2026, 7:23PM Disclosure under Regulation 30 of SEBI LODR regarding earnings presentation for Q4 & FY26.

  • Zim Laboratories - General Updates

    19 May 2026, 7:16PM Zim Laboratories Limited has informed the Exchange about earnings presentation for Q4 & FY26

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 May 2026, 6:12PM Please find attached a press release dated 19th May 2026 titled \ZIM Laboratories Limited announces grant of Marketing Authorization (MA) for Dabigatr

  • Zim Laboratories - Press Release

    19 May 2026, 6:03PM Zim Laboratories Limited has informed the Exchange regarding a press release dated May 19, 2026, titled ""ZIM Laboratories Limited Announces Grant of

  • Zim Laboratories - Change in Auditors

    19 May 2026, 4:45PM Zim Laboratories Limited has informed the Exchange regarding Change in Auditors of the company.

  • Zim Laboratories - Outcome of Board Meeting

    19 May 2026, 4:42PM Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

  • Zim Laboratories - Results - Financial Results For 31.03.2026

    19 May 2026, 5:29PM Pursuant to Regulation 33, please find attached the Financial Results (Standalone and Consolidated) of the Company for the year ended 31.03.2026

  • Zim Laboratories Q4 net profit down 39.48% at Rs 3.28 cr

    19 May 2026, 5:10PM The company reported standalone net profit of Rs 3.28 crore for the quarter ended March 31, 2026 as compared to Rs 5.42 crore in the same period last

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    19 May 2026, 4:56PM Appointment of M/s. Dhananjay V. Joshi & Associates, Cost Accountants as the Cost Auditor for the F.Y. 2026-27

  • Zim Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting Held On 19.05.2026

    19 May 2026, 4:53PM Outcome of the Board meeting held on 19.05.2026

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 May 2026, 8:24PM Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    13 May 2026, 8:20PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Board Meeting Intimation for Consideration And Approval Of The Audited Standalone And Consolidated Financi

    12 May 2026, 5:06PM Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    8 May 2026, 7:43PM The Nomination and Remuneration Committee of the Board on 08.05.2026 has approved the grant of 1,29,200 options to the eligible employee of the Compan

  • Zim Laboratories - ESOP/ESOS/ESPS

    8 May 2026, 7:38PM Zim Laboratories Limited has informed the Exchange regarding Grant of 129200 Options.

  • Zim Laboratories - Update - Completion Of EU-GMP Inspection / Audit

    8 May 2026, 5:47PM This is to inform that the manufacturimg facility of the Company underwent an inspection conducted by German and Portuguese Authority. The inspection

  • Zim Laboratories - General Updates

    8 May 2026, 5:43PM Zim Laboratories Limited has informed the Exchange about General Updates

  • Zim Laboratories - Disclosure under SEBI Takeover Regulations

    29 Apr 2026, 5:22PM Zulfiquar M Kamal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    18 Apr 2026, 4:16PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, please find enclosed the disclosure w.r.t allotment of 48,726 equity shares pursuant to exercise

  • Zim Laboratories - ESOP/ESOS/ESPS

    18 Apr 2026, 4:06PM Zim Laboratories Limited has informed the Exchange regarding Allotment of 48726 Shares.

  • Zim Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    18 Apr 2026, 4:02PM As of March 2026, 30.35% is owned by Indian Promoters and 69.65% by Public. <p align=justify> Top five Promoters holding highest number of shares of Z
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Zim Laboratories Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 409.336 356.6793 338.3068 253.7463 221.2899
Liabilities 409.336 356.6793 338.3068 253.7463 221.2899
Equity 53.5003 48.7258 48.7258 48.7258 16.2419
Gross Profit 29.58 43.2684 40.1024 51.1911 37.934
Net Profit 5.9652 11.744 16.7555 25.0088 13.0128
Cash From Operating Activities 47.6584 50.602 11.472 35.2318 47.0265
NPM(%) 1.61 3.12 4.58 6.3 3.94
Revenue 370.4815 375.6355 365.4732 396.5313 329.4937
Expenses 340.9015 332.3671 325.3708 345.3402 291.5597
ROE(%) 2.01 3.96 5.65 8.44 4.39

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Zim Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 701.25 0.68 0.00 64.92 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 118.28 -2.34 3942.67 236.56 0.39 0.00
Vaishali Pharma Ltd 7.56 5.00 25.20 1484.01 15.42 0.00
Astec Lifesciences Ltd 689.20 0.37 0.00 253.46 -363.14 0.00

Company Info

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023. 2025-ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announced Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region.

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023. 2025-ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announced Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region.

Parent Organisation

Zim Laboratories Ltd.

Founded

14/02/1984

Managing Director

Dr.Anwar Daud

NSE Symbol

ZIMLABBE

FAQ